Magnolia Medical Technologies is a San Mateo-based company that is dedicated to delivering breakthrough solutions in diagnostic accuracy to support better clinical decisions and improve patient outcomes. Their mission is to create new standards in healthcare by providing evidence-backed solutions, such as the Steripath Initial Diversion Device, which has been proven to significantly reduce blood culture contamination for sepsis testing accuracy.
With a focus on diagnostic stewardship, Magnolia Medical aims to mitigate the harmful clinical and cost consequences of false-positive blood culture results, which can lead to unnecessary antibiotic use and adverse drug events. Trusted by hospitals and healthcare systems nationwide, their innovative solutions have been published in reputable medical journals and have the potential to revolutionize the diagnostic accuracy and timeliness of sepsis test results.
Generated from the website